AKCEA THERAPEUTICS INC - COM (AKCA)

CUSIP: 00972L107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM
Total 13F shares
20,422,303
Share change
-476,561
Total reported value
$292,045,584
Put/Call ratio
114%
Price per share
$14.30
Number of holders
76
Value change
-$7,466,946
Number of buys
36
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 00972L107?
CUSIP 00972L107 identifies AKCA - AKCEA THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q1 2020

As of 31 Mar 2020, AKCEA THERAPEUTICS INC - COM (AKCA) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,422,303 shares. The largest 10 holders included FMR LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, ALPS ADVISORS INC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 76 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.